Kevin Caliendo
Stock Analyst at UBS
(4.08)
# 480
Out of 5,090 analysts
202
Total ratings
66.02%
Success rate
7.53%
Average return
Main Sectors:
Stocks Rated by Kevin Caliendo
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SOLV Solventum | Maintains: Neutral | $77 → $79 | $85.43 | -7.53% | 2 | Nov 10, 2025 | |
| LFST LifeStance Health Group | Maintains: Buy | $9 → $10 | $6.48 | +54.32% | 6 | Nov 7, 2025 | |
| COR Cencora | Maintains: Buy | $380 → $415 | $339.66 | +22.18% | 4 | Nov 7, 2025 | |
| GDRX GoodRx Holdings | Maintains: Neutral | $4.25 → $4 | $2.71 | +47.60% | 7 | Nov 6, 2025 | |
| MCK McKesson | Maintains: Buy | $920 → $980 | $808.62 | +21.19% | 17 | Nov 6, 2025 | |
| OMI Owens & Minor | Downgrades: Neutral | $7 → $4 | $2.59 | +54.44% | 7 | Nov 3, 2025 | |
| CAH Cardinal Health | Maintains: Buy | $185 → $220 | $198.83 | +10.65% | 18 | Oct 31, 2025 | |
| ALHC Alignment Healthcare | Maintains: Neutral | $17 → $18 | $19.55 | -7.93% | 8 | Oct 31, 2025 | |
| UNH UnitedHealth Group | Maintains: Buy | $378 → $430 | $330.91 | +29.94% | 13 | Oct 29, 2025 | |
| LH Labcorp Holdings | Maintains: Buy | $325 → $320 | $258.39 | +23.84% | 7 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $24 → $23 | $11.25 | +104.44% | 12 | Oct 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $180 → $170 | $151.86 | +11.95% | 5 | Oct 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $79 → $96 | $75.63 | +26.93% | 10 | Oct 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $180 → $190 | $182.51 | +4.10% | 16 | Oct 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $160 → $155 | $157.21 | -1.41% | 19 | Oct 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $75 → $70 | $73.62 | -4.92% | 6 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $18 → $22 | $20.23 | +8.75% | 4 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $15 | $3.94 | +280.71% | 3 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $12 → $9 | $4.01 | +124.44% | 3 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $410 → $390 | $265.44 | +46.93% | 11 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $380 → $250 | $257.85 | -3.04% | 6 | Oct 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $72 → $79 | $38.34 | +106.05% | 2 | Dec 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $610 → $575 | $330.75 | +73.85% | 1 | Jul 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $185 → $180 | $201.93 | -10.86% | 7 | Jul 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $130 → $72 | $7.59 | +848.62% | 4 | Mar 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $15 → $11 | $28.46 | -61.35% | 4 | May 4, 2021 |
Solventum
Nov 10, 2025
Maintains: Neutral
Price Target: $77 → $79
Current: $85.43
Upside: -7.53%
LifeStance Health Group
Nov 7, 2025
Maintains: Buy
Price Target: $9 → $10
Current: $6.48
Upside: +54.32%
Cencora
Nov 7, 2025
Maintains: Buy
Price Target: $380 → $415
Current: $339.66
Upside: +22.18%
GoodRx Holdings
Nov 6, 2025
Maintains: Neutral
Price Target: $4.25 → $4
Current: $2.71
Upside: +47.60%
McKesson
Nov 6, 2025
Maintains: Buy
Price Target: $920 → $980
Current: $808.62
Upside: +21.19%
Owens & Minor
Nov 3, 2025
Downgrades: Neutral
Price Target: $7 → $4
Current: $2.59
Upside: +54.44%
Cardinal Health
Oct 31, 2025
Maintains: Buy
Price Target: $185 → $220
Current: $198.83
Upside: +10.65%
Alignment Healthcare
Oct 31, 2025
Maintains: Neutral
Price Target: $17 → $18
Current: $19.55
Upside: -7.93%
UnitedHealth Group
Oct 29, 2025
Maintains: Buy
Price Target: $378 → $430
Current: $330.91
Upside: +29.94%
Labcorp Holdings
Oct 29, 2025
Maintains: Buy
Price Target: $325 → $320
Current: $258.39
Upside: +23.84%
Oct 28, 2025
Maintains: Buy
Price Target: $24 → $23
Current: $11.25
Upside: +104.44%
Oct 24, 2025
Maintains: Neutral
Price Target: $180 → $170
Current: $151.86
Upside: +11.95%
Oct 24, 2025
Maintains: Buy
Price Target: $79 → $96
Current: $75.63
Upside: +26.93%
Oct 17, 2025
Maintains: Neutral
Price Target: $180 → $190
Current: $182.51
Upside: +4.10%
Oct 16, 2025
Maintains: Neutral
Price Target: $160 → $155
Current: $157.21
Upside: -1.41%
Aug 6, 2025
Maintains: Neutral
Price Target: $75 → $70
Current: $73.62
Upside: -4.92%
Jul 29, 2025
Maintains: Neutral
Price Target: $18 → $22
Current: $20.23
Upside: +8.75%
May 9, 2025
Maintains: Buy
Price Target: $14 → $15
Current: $3.94
Upside: +280.71%
May 8, 2025
Maintains: Neutral
Price Target: $12 → $9
Current: $4.01
Upside: +124.44%
Feb 3, 2025
Maintains: Buy
Price Target: $410 → $390
Current: $265.44
Upside: +46.93%
Oct 4, 2024
Maintains: Neutral
Price Target: $380 → $250
Current: $257.85
Upside: -3.04%
Dec 21, 2023
Maintains: Neutral
Price Target: $72 → $79
Current: $38.34
Upside: +106.05%
Jul 13, 2023
Maintains: Buy
Price Target: $610 → $575
Current: $330.75
Upside: +73.85%
Jul 21, 2022
Maintains: Neutral
Price Target: $185 → $180
Current: $201.93
Upside: -10.86%
Mar 8, 2022
Maintains: Neutral
Price Target: $130 → $72
Current: $7.59
Upside: +848.62%
May 4, 2021
Downgrades: Neutral
Price Target: $15 → $11
Current: $28.46
Upside: -61.35%